Translational Research
Volume 156, Issue 4 , Pages 235-241, October 2010

Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study

  • José R. Romero

      Affiliations

    • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
  • ,
  • Amy J. Castonguay

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
  • ,
  • Nathaniel S. Barton

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
  • ,
  • Soren Germer

      Affiliations

    • Translational Research Sciences, Hoffmann-La Roche, Nutley, NJ
  • ,
  • Mitchell Martin

      Affiliations

    • Translational Research Sciences, Hoffmann-La Roche, Nutley, NJ
  • ,
  • Robert Y.L. Zee

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
    • Corresponding Author InformationReprint requests: Dr. Robert Y.L. Zee, MD, Brigham and Women’s Hospital, Preventive Medicine, Harvard Medical School, 900 Commonwealth Avenue East, Boston, MA 02215

Received 11 May 2010; received in revised form 29 June 2010; accepted 7 July 2010. published online 09 August 2010.

Transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), have been implicated in inflammatory disorders including diabetes, a major source of morbidity and mortality in developing and Western society. We hypothesized that gene variation of TRPM6 and TRPM7 may play a role in type 2 diabetes mellitus (T2DM) Using a case-control population sample of the Boston metropolitan area (all whites, 455 controls and 467 cases), we assessed the relationship of 29 TRPM6 and 11 TRPM7 tag-single nucleotide polymorphisms (SNPs) with (1) several diabetes-related intermediate phenotypes (fasting insulin levels, fasting glucose levels, hemoglobin A1c, and homeostatic model assessment) and (2) the presence of T2DM. All SNPs examined were in Hardy–Weinberg equilibrium. Overall, genotype distributions were similar between cases and controls. Linear regression analysis, adjusted for potential risk factors/confounders, showed no evidence of an association of any SNPs tested with the aforementioned diabetes-related intermediate phenotypes after correcting for multiple testing. Marker-by-marker multivariable logistic regression analysis showed no evidence of an association of any SNPs tested with the presence of T2DM after correcting for multiple testing. Continued investigation using an entropy-blocker-defined haplotype-based approach showed similar null findings. If corroboration occurs in future large prospective investigations, then the present investigation further suggests that TRPM6 and TRPM7 gene variation may not be useful predictors for T2DM risk assessment.

Abbreviations: CI, confidence interval, EB, entropy blocker, HbA1c, hemoglobin A1c, HOMA-%B, homeostatic model assessment-β-cell function, HOMA-IR, homeostatic model assessment-insulin resistance, LD, linkage disequilibrium, MAF, minor allele frequency, MDR, multifactor dimensionality reduction, MIM, Mendelian Inheritance in Man, OR, Odds ratio, SNP, single nucleotide polymorphism, T2DM, type 2 diabetes mellitus, TRPM6, transient receptor potential melastatin 6, TRPM7, transient receptor potential melastatin 7

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by F. Hoffmann La-Roche and the National Heart, Lung and Blood Institute/NIH (RO1-HL096518).

 Conflict-of-interest disclosure: Soren Germer and Mitchell Martin are employees of F. Hoffmann La-Roche.

PII: S1931-5244(10)00149-0

doi:10.1016/j.trsl.2010.07.001

Translational Research
Volume 156, Issue 4 , Pages 235-241, October 2010